Knopp Biosciences: A Biotechnology Company Seeking to Improve Lives

For Patients and Families For Healthcare Professionals

Are you a healthcare professional?

Go back

Life Changing Medicine

Discovering, Developing, and Delivering Breakthrough Medications

Discover our current investigational platforms:

Dexpramipexole

An Uncommon Approach to Severe Asthma

In development for patients with moderate-to-severe eosinophilic asthma
50% of asthma patients have increased levels of inflammatory eosinophils

Drugs approved for eosinophilic asthma must be injected or infused. Knopp is developing an oral medication for eosinophilic asthma.

Discover Dexpramipexole Read More About Our Phase 2 Study

Knopp Biosciences

A Biotechnology Company Seeking to Save Lives

Neurological Diseases
Immunological Conditions

Knopp Disclaimer

Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.